- Home
- GMAB vs LOGI Comparison
GMAB vs LOGI Comparison
Compare GMAB & LOGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMAB
- LOGI
- Stock Information
- Founded
- GMAB 1999
- LOGI 1981
- Country
- GMAB Denmark
- LOGI Switzerland
- Employees
- GMAB N/A
- LOGI N/A
- Industry
- GMAB Biotechnology: Pharmaceutical Preparations
- LOGI Computer peripheral equipment
- Sector
- GMAB Health Care
- LOGI Technology
- Exchange
- GMAB Nasdaq
- LOGI Nasdaq
- Market Cap
- GMAB 15.0B
- LOGI 12.4B
- IPO Year
- GMAB N/A
- LOGI 1997
- Fundamental
- Price
- GMAB $21.80
- LOGI $90.20
- Analyst Decision
- GMAB Buy
- LOGI Hold
- Analyst Count
- GMAB 8
- LOGI 10
- Target Price
- GMAB $43.00
- LOGI $92.88
- AVG Volume (30 Days)
- GMAB 1.1M
- LOGI 484.7K
- Earning Date
- GMAB 02-12-2025
- LOGI 01-28-2025
- Dividend Yield
- GMAB N/A
- LOGI 2.94%
- EPS Growth
- GMAB 14.35
- LOGI 89.87
- EPS
- GMAB 10.80
- LOGI 4.50
- Revenue
- GMAB $2,967,926,227.00
- LOGI $4,471,211,000.00
- Revenue This Year
- GMAB $32.03
- LOGI $6.29
- Revenue Next Year
- GMAB $16.97
- LOGI $4.75
- P/E Ratio
- GMAB $19.02
- LOGI $20.05
- Revenue Growth
- GMAB 17.75
- LOGI 4.92
- 52 Week Low
- GMAB $19.85
- LOGI $74.72
- 52 Week High
- GMAB $31.88
- LOGI $102.59
- Technical
- Relative Strength Index (RSI)
- GMAB 54.72
- LOGI 68.11
- Support Level
- GMAB $19.89
- LOGI $86.69
- Resistance Level
- GMAB $21.26
- LOGI $88.88
- Average True Range (ATR)
- GMAB 0.42
- LOGI 1.45
- MACD
- GMAB 0.02
- LOGI 0.46
- Stochastic Oscillator
- GMAB 80.08
- LOGI 96.79
About GMAB Genmab A/S ADS
Genmab AS is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.
About LOGI Logitech International S.A.
Logitech was founded in 1981 and is headquartered in Lausanne, Switzerland. The company specializes in designing and manufacturing computer peripherals such as mice, keyboards, webcams, conference room cameras, headsets, and music-related products such as wireless speakers.